2022-RA-937-ESGO Rucaparib MAintenance after bevacizumab maintenance following carboplatin based chemotherapy in primary ovarian cancer | International Journal of Gynecologic Cancer

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

YouTube

Podcasts

Zoom Journal Club
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Ovarian cancer

2022-RA-937-ESGO Rucaparib MAintenance after bevacizumab maintenance following carboplatin based chemotherapy in primary ovarian cancer

Free

Online download statistics by month:

Online download statistics by month: October 2022 to April 2024

	Abstract	Full	Pdf
Oct 2022	20	0	3
Nov 2022	43	0	4
Dec 2022	54	0	7
Jan 2023	37	0	9
Feb 2023	15	0	3
Mar 2023	9	0	1
Apr 2023	36	0	3
May 2023	14	0	2
Jun 2023	4	0	1
Jul 2023	22	0	5
Aug 2023	10	0	4
Sep 2023	25	0	7
Oct 2023	23	0	8
Nov 2023	17	0	3
Dec 2023	17	0	2
Jan 2024	10	0	3
Feb 2024	19	0	4
Mar 2024	14	0	23
Apr 2024	10	0	5
Total	399	0	97